Archive for February, 2016


February 23, 2016


SAN DIEGO, Feb. 22, 2016 /PRNewswire/ — Tamir Biotechnology, a clinical stage company developing ranpirnase as a novel broad-spectrum anti-viral, announced results today from a pre-clinical investigational study at the Institute of Antiviral Research at Utah State University.

Read the full article here.
From prnewswire.com

Continue reading
Back to top